Article
Plasmodium falciparum histidine rich protein 2 (pfhrp2): an additional genetic marker suitable for anti-malarial drug efficacy trials.
Malaria journal - 4 Jan 2022
Atroosh Wahib M, Lau Yee-Ling, Snounou Georges, Azzani Meram, Al-Mekhlafi Hesham M
Abstract excerpt
BACKGROUND: Genotyping of the three Plasmodium falciparum polymorphic genes, msp1, msp2 and glurp, has been adopted as a standard strategy to distinguish recrudescence from new infection in drug efficacy clinical trials. However, the suitability of a particular gene is compromised in areas where its allelic variants distribution is significantly skewed, a phenomenon that might occur in isolated parasite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
